Balter Liquid Alternatives’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$2.63M Buy
48,348
+15,510
+47% +$835K 1.28% 25
2019
Q1
$1.77M Buy
32,838
+13,296
+68% +$821K 0.98% 35
2018
Q4
$1.28M Buy
19,542
+3,039
+18% +$227K 0.89% 34
2018
Q3
$1.3M Buy
16,503
+4,841
+42% +$346K 1.06% 23
2018
Q2
$760K Buy
11,662
+4,824
+71% +$318K 0.59% 49
2018
Q1
$425K Buy
6,838
+1,698
+33% +$122K 0.41% 84
2017
Q4
$373K Buy
5,140
+333
+7% +$24.2K 0.37% 94
2017
Q3
$391K Hold
4,807
0.44% 78
2017
Q2
$387K Buy
+4,807
New +$380K 0.45% 66

Other funds holding CVS

Balter Liquid Alternatives's CVS Position: Q2 2019 in Review

Balter Liquid Alternatives increased its CVS Health (CVS) stake by 47% in Q2 2019, buying an estimated $835K and bringing the position to 48,348 shares worth $2.63M. The position accounts for 1.28% of the portfolio, ranked #25.

Balter Liquid Alternatives first reported a position in CVS in Q2 2017 and has held it in 9 quarters since. 1,654 funds tracked by Wall St. Rank hold CVS as of Q2 2019.

  • Balter Liquid Alternatives held 48,348 shares of CVS Health worth $2.63M as of Q2 2019.
  • Balter Liquid Alternatives bought 15,510 CVS Health shares in Q2 2019, an estimated $835K.
  • CVS Health made up 1.28% of Balter Liquid Alternatives's portfolio in Q2 2019, its #25 holding.
  • Balter Liquid Alternatives first reported a position in CVS Health in Q2 2017 and has held it in 9 quarters since.
  • 1,654 funds tracked by Wall St. Rank held CVS Health as of Q2 2019.

Based on Balter Liquid Alternatives's 13F filing for Q2 2019, filed 31 Jul 2019.